| Anti-angiogenic properties of ginsenoside Rg3 epimers: In vitro assessment of single and combination treatments M Nakhjavani, E Smith, K Yeo, HM Palethorpe, Y Tomita, TJ Price, ... Cancers 13 (9), 2223, 2021 | 17 | 2021 |
| The antianginal drug perhexiline displays cytotoxicity against colorectal cancer cells in vitro: a potential for drug repurposing B Dhakal, CMY Li, R Li, K Yeo, JA Wright, KA Gieniec, L Vrbanac, ... Cancers 14 (4), 1043, 2022 | 12 | 2022 |
| Anti-cancer effects of an optimised combination of ginsenoside Rg3 epimers on triple negative breast cancer models M Nakhjavani, E Smith, HM Palethorpe, Y Tomita, K Yeo, TJ Price, ... Pharmaceuticals 14 (7), 633, 2021 | 8 | 2021 |
| Differential antiangiogenic and anticancer activities of the active metabolites of ginsenoside Rg3 M Nakhjavani, E Smith, K Yeo, Y Tomita, TJ Price, A Yool, AR Townsend, ... Journal of Ginseng Research, 2021 | 6 | 2021 |
| In Vitro Synergistic Inhibition of HT-29 Proliferation and 2H-11 and HUVEC Tubulogenesis by Bacopaside I and II Is Associated with Ca2+ Flux and Loss of Plasma … Y Tomita, E Smith, HM Palethorpe, M Nakhjavani, KKL Yeo, ... Pharmaceuticals 14 (5), 436, 2021 | 3 | 2021 |
| Identification of consensus head and neck cancer-associated microbiota signatures: a systematic review and meta-analysis of 16S rRNA and The Cancer Microbiome Atlas datasets K Yeo, R Li, F Wu, G Bouras, LTH Mai, E Smith, PJ Wormald, R Valentine, ... Journal of Medical Microbiology 73 (2), 001799, 2024 | 1 | 2024 |
| Enhanced phylogenetic insights into the microbiome of chronic rhinosinusitis through the novel application of long read 16S rRNA gene amplicon sequencing. JT Connell, K Yeo, G Bouras, A Bassiouni, K Fenix, C Cooksley, ... Rhinology, 2024 | 1 | 2024 |
| Elucidating the mechanism of cell death by bacopaside II in triple-negative breast cancer K Yeo | 1 | 2020 |
| Diagnostic and prognostic significance of circulating secreted frizzled‐related protein 5 in colorectal cancer R Li, S Liu, K Yeo, S Edwards, MY Li, R Santos, SK Rad, F Wu, ... Cancer Medicine 13 (11), e7352, 2024 | | 2024 |
| A comparison between full-length 16S rRNA Oxford nanopore sequencing and Illumina V3-V4 16S rRNA sequencing in head and neck cancer tissues K Yeo, J Connell, G Bouras, E Smith, W Murphy, JC Hodge, S Krishnan, ... Archives of Microbiology 206 (6), 248, 2024 | | 2024 |
| Metagenomics or Metataxonomics: Best Practice Methods to Uncover the Sinus Microbiome I Burdon, G Bouras, K Fenix, K Yeo, J Connell, C Cooksley, E Barry, ... | | 2024 |
| Circulating SFRP5 levels are elevated in colorectal cancer and correlate with overall survival in stage II-III disease R Li, S Liu, K Yeo, S Edwards, MY Li, R Santos, S Kianpour Rad, F Wu, ... medRxiv, 2024.03. 14.24304260, 2024 | | 2024 |
| A comparison between full-length 16S rRNA Oxford Nanopore sequencing and Illumina V3-V4 16S rRNA sequencing in head and neck cancer tissues K Yeo, J Connell, G Bouras, E Smith, W Murphy, JC Hodge, S Krishnan, ... bioRxiv, 2024.03. 08.584026, 2024 | | 2024 |
| Identification of consensus head and neck cancer-associated microbiota signatures: a meta-analysis of 16S rRNA and The Cancer Microbiome Atlas datasets. K Yeo, R Li, F Wu, G Bouras, LTH Mai, E Smith, PJ Wormald, R Valentine, ... medRxiv, 2023.07. 25.23293137, 2023 | | 2023 |
